106 related articles for article (PubMed ID: 24355005)
41. ATB(0)/SLC1A5 gene. Fine localisation and exclusion of association with the intestinal phenotype of cystic fibrosis.
Larriba S; Sumoy L; Ramos MD; Giménez J; Estivill X; Casals T; Nunes V
Eur J Hum Genet; 2001 Nov; 9(11):860-6. PubMed ID: 11781704
[TBL] [Abstract][Full Text] [Related]
42. Variants in the glutamate-cysteine-ligase gene are associated with cystic fibrosis lung disease.
McKone EF; Shao J; Frangolias DD; Keener CL; Shephard CA; Farin FM; Tonelli MR; Pare PD; Sandford AJ; Aitken ML; Kavanagh TJ
Am J Respir Crit Care Med; 2006 Aug; 174(4):415-9. PubMed ID: 16690975
[TBL] [Abstract][Full Text] [Related]
43. Temporal bone pneumatization in cystic fibrosis: a correlation with genotype?
Berkhout MC; van Rooden CJ; Aalbers RC; el Bouazzaoui LH; Fokkens WJ; Rijntjes E; Heijerman HG
Laryngoscope; 2014 Jul; 124(7):1682-6. PubMed ID: 24374715
[TBL] [Abstract][Full Text] [Related]
44. Rhinosinusitis in the pediatric patient with cystic fibrosis.
Fundakowski C; Ojo R; Younis R
Curr Pediatr Rev; 2014; 10(3):198-201. PubMed ID: 25088340
[TBL] [Abstract][Full Text] [Related]
45. The Role of HLA-DRB1 Alleles in Pulmonary Cystic Fibrosis.
Asef A; Ghafaripour HA; Jamaati H; Varahram M; M Adcock I; Mortaz E
Iran J Allergy Asthma Immunol; 2022 Apr; 21(2):189-196. PubMed ID: 35490272
[TBL] [Abstract][Full Text] [Related]
46. An alpha1-antitrypsin enhancer polymorphism is a genetic modifier of pulmonary outcome in cystic fibrosis.
Henry MT; Cave S; Rendall J; O'Connor CM; Morgan K; FitzGerald MX; Kalsheker N
Eur J Hum Genet; 2001 Apr; 9(4):273-8. PubMed ID: 11313771
[TBL] [Abstract][Full Text] [Related]
47. Association between the IVS4G>T mutation in the TCF7L2 gene and susceptibility to diabetes in cystic fibrosis patients.
Furgeri DT; Marson FA; Ribeiro AF; Bertuzzo CS
BMC Res Notes; 2012 Oct; 5():561. PubMed ID: 23050589
[TBL] [Abstract][Full Text] [Related]
48. Susceptibility to typhoid fever is associated with a polymorphism in the cystic fibrosis transmembrane conductance regulator (CFTR).
van de Vosse E; Ali S; de Visser AW; Surjadi C; Widjaja S; Vollaard AM; van Dissel JT
Hum Genet; 2005 Oct; 118(1):138-40. PubMed ID: 16078047
[TBL] [Abstract][Full Text] [Related]
49. Cystic fibrosis modifier genes.
Davies J; Alton E; Griesenbach U
J R Soc Med; 2005; 98 Suppl 45(Suppl 45):47-54. PubMed ID: 16025767
[TBL] [Abstract][Full Text] [Related]
50. Cystic fibrosis and HLA.
Hennequet A; Jehanne M; Betuel H; Gilly R; Schmid M; Hors J
Tissue Antigens; 1978 Sep; 12(3):159-62. PubMed ID: 725903
[TBL] [Abstract][Full Text] [Related]
51. Genetic Variation Near chrXq22-q23 Is Linked to Emotional Functioning in Cystic Fibrosis.
Barbato E; Daly B; Douglas S; Kerr M; Litman P; Darrah R
Biol Res Nurs; 2020 Jul; 22(3):319-325. PubMed ID: 32390518
[TBL] [Abstract][Full Text] [Related]
52. [Clinical significance of specific features of HLA antigen incidence in patients with mucoviscidosis and in their relatives].
Gembitskaia TE; Kocharian RKh; Petrova MA
Vestn Ross Akad Med Nauk; 1996; (3):41-4. PubMed ID: 8672961
[TBL] [Abstract][Full Text] [Related]
53. Absence of an association between HLA typing in cystic fibrosis arthritis and hypertrophic osteoarthropathy.
Rush PJ; Gladman DD; Shore A; Anhorn KA
Ann Rheum Dis; 1991 Nov; 50(11):763-4. PubMed ID: 1772290
[TBL] [Abstract][Full Text] [Related]
54. Rash in lapatinib-treated patients is not associated with human leukocyte antigen polymorphisms.
Parham LR; Briley LP; King KS; Byrne J; Rappold E; Goss PE; Spraggs CF
Pharmacogenomics; 2015; 16(11):1227-9. PubMed ID: 26265235
[TBL] [Abstract][Full Text] [Related]
55. Distribution of HLA antigens in idiopathic pulmonary fibrosis.
Fulmer JD; Sposovska MS; von Gal ER; Crystal RG; Mittal KK
Am Rev Respir Dis; 1978 Jul; 118(1):141-7. PubMed ID: 677553
[TBL] [Abstract][Full Text] [Related]
56. Rare disorder could provide target for CF therapy.
Dorrell S
Mol Med Today; 1999 Nov; 5(11):462. PubMed ID: 10529785
[No Abstract] [Full Text] [Related]
57. Secondary genetic factors in cystic fibrosis lung disease.
Mahadeva R; Lomas DA
Thorax; 2000 Jun; 55(6):446. PubMed ID: 10817788
[No Abstract] [Full Text] [Related]
58. T cell receptor beta chain polymorphisms are associated with cystic fibrosis.
McMillan SA; Hill AJ; Graham CA; Nevin NC; Fay AC
J Med Genet; 1989 Jul; 26(7):431-3. PubMed ID: 2568490
[TBL] [Abstract][Full Text] [Related]
59. Gene modifiers in cystic fibrosis.
Accurso FJ; Sontag MK
J Clin Invest; 2008 Mar; 118(3):839-41. PubMed ID: 18292812
[TBL] [Abstract][Full Text] [Related]
60. Modulation of cystic fibrosis lung disease by variants in interleukin-8.
Hillian AD; Londono D; Dunn JM; Goddard KA; Pace RG; Knowles MR; Drumm ML;
Genes Immun; 2008 Sep; 9(6):501-8. PubMed ID: 18563170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
